Search

everythinglearnresearchcommunity

for

Search:↓

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

New drugs for heart disease may be developed from molecules secreted by stem cells.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Isotretinoin can cause serious birth defects and needs careful use, especially in pregnant women.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

The document concludes that more research is needed to fully understand the causes of PCOS.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.